Siti Saidah Mutmainah

Siti Saidah Mutmainah

Auto-generated profile, based on publicly available information

Siti Saidah Mutmainah

Faculty of Pharmacy, Bhakti Kencana University, Bandung, Indonesia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2025 in Journal of Oncology Pharmacy Practice
Verified
Journal Article
Closed access
AAAni Anggriani
Ani Anggriani
EHEli Halimah
Eli Halimah
SMSiti Saidah Mutmainah
Siti Saidah Mutmainah
Farida RendrayaniFarida Rendrayani
Farida Rendrayani
RSRano Sinuraya
Rano Sinuraya
IPIrma Melyani Puspitasari
Irma Melyani Puspitasari
Introduction: Clinical pharmacists play a crucial role in identifying drug-related problems (DRPs) during the assessment of chemotherapy regimens. In hospitals, this assessment involves identification, intervention, and resolution. However, since the process is largely conducted manually, it becomes time-consuming and inefficient. This study aims to explore the perspectives of clinical pharmacists regarding the current chemotherapy regimen DRPs assessment process and the need for an application (app) to improve and streamline this assessment. Methods: A focus group discussion (FGD) was conducted with 11 clinical pharmacists responsible for reviewing chemotherapy regimens at a hospital in Indonesia. The discussions were recorded, transcribed, and analyzed using NVivo 15.0.0. Results: The current DRPs assessment is time-consuming due to redundant documentation, requiring daily data entry and reentry for monthly reports. Issues include long processing times and potential body surface area (BSA) and dose calculation errors. Clinical pharmacists expressed the need for a DRPs app to streamline workflow and reduce errors. They emphasized clear, readable fonts, a purple color scheme, and a comprehensive drug database aligned with hospital, Ministry of Health, and national formulary standards. The app should be user-friendly and accessible on both computers and smartphones. Conclusions: This study highlights that the current manual handwriting-based DRPs assessment process for chemotherapy regimens is inefficient and requires repeated documentation. Clinical pharmacists strongly advocate for the development of an app that streamlines the assessment of DRPs, facilitates accurate and timely reporting of medication errors, and enhances overall efficiency in chemotherapy regimen evaluations.